Page last updated: 2024-10-19

niacinamide and Hypertrophy, Left Ventricular

niacinamide has been researched along with Hypertrophy, Left Ventricular in 2 studies

nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.

Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Daryadel, A1
Bogdanova, A1
Gassmann, M1
Mueller, X1
Zünd, G1
Seifert, B1
Lehalle, C1
Frossard, N1
Tavakoli, R1
Alcendor, RR1
Kirshenbaum, LA1
Imai, S1
Vatner, SF1
Sadoshima, J1

Other Studies

2 other studies available for niacinamide and Hypertrophy, Left Ventricular

ArticleYear
Multikinase inhibitor sorafenib prevents pressure overload-induced left ventricular hypertrophy in rats by blocking the c-Raf/ERK1/2 signaling pathway.
    Journal of cardiothoracic surgery, 2014, May-09, Volume: 9

    Topics: Animals; Becaplermin; Blood Pressure; Blotting, Western; Disease Models, Animal; Enzyme-Linked Immun

2014
Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes.
    Circulation research, 2004, Nov-12, Volume: 95, Issue:10

    Topics: Acetylation; Alkaloids; Animals; Apoptosis; Atrial Natriuretic Factor; Benzamides; Benzophenanthridi

2004